Representatives of key international and national diabetes organizations, clinicians, researchers, people with diabetes and their family members gathered in Copenhagen on the 2nd and 3rd of November 2012 to review the initial results of the study.
Watch interviews with some of the delegates to the global results meeting to hear their views in relation to DAWN2™.Through the voices of a father, a son and a daughter of our employees, the story about Novo...
Nearly two-thirds of all people with diabetes live in cities. It's an emergency in slow motion....
Learn how Novo Nordisk and suppliers collaborate on reducing carbon emissions
Ahmad is one of more than one hundred people to have participated in Novo Nordisk’s internship...
Tanner Barton, who has type 1 diabetes, and patient organisations have helped us make our...
All throughout the month of May, we bike to work #TheDanishWay
